Diseases, Conditions, Syndromes

Convalescent plasma treatment added to Australian COVID-19 trials

Convalescent plasma has been introduced to the AustralaSian COVID-19 Trial (ASCOT) and Randomized, Embedded, Multi-factorial, Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP) clinical trials in a bid to ...

Diseases, Conditions, Syndromes

Convalescent plasma: A COVID-19 treatment speeds to clinical trials

In January 1934, J. Roswell Gallagher faced a major problem. The staff physician at a boys' boarding school outside Philadelphia learned that one pupil, identified as C. Y., had been exposed to measles. While confined to ...


Malaria drug chloroquine does not inhibit SARS-CoV-2

More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2). In order to obtain an effective therapy for COVID-19 as quickly as possible, ...


Unlocking the key to an effective vaccine

A recent study by Monash University has looked at the role plasma cells and their longevity play in the effectiveness of vaccines in the body and suggests that components within vaccine design are the key.

Medical research

Bioelectric signals in breast cancer metastasis studied

Metastasis accounts for approximately 90 percent of mortality in breast cancer patients. During the last few decades, there has been significant progress in understanding genetic, molecular and signaling mechanisms underpinning ...

Medical research

Diluting blood plasma rejuvenates tissue, reverses aging in mice

In 2005, University of California, Berkeley, researchers made the surprising discovery that making conjoined twins out of young and old mice—such that they share blood and organs—can rejuvenate tissues and reverse the ...

page 1 from 47